These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30944096)

  • 1. OTUB1 inhibits CNS autoimmunity by preventing IFN-γ-induced hyperactivation of astrocytes.
    Wang X; Mulas F; Yi W; Brunn A; Nishanth G; Just S; Waisman A; Brück W; Deckert M; Schlüter D
    EMBO J; 2019 May; 38(10):. PubMed ID: 30944096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
    Smith BC; Sinyuk M; Jenkins JE; Psenicka MW; Williams JL
    J Neuroinflammation; 2020 Jun; 17(1):184. PubMed ID: 32532298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
    Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A
    J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity.
    Yi W; Schlüter D; Wang X
    Brain Behav Immun; 2019 Aug; 80():10-24. PubMed ID: 31125711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis.
    Glabinski AR; Krakowski M; Han Y; Owens T; Ransohoff RM
    J Neurovirol; 1999 Feb; 5(1):95-101. PubMed ID: 10190695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
    Rothhammer V; Mascanfroni ID; Bunse L; Takenaka MC; Kenison JE; Mayo L; Chao CC; Patel B; Yan R; Blain M; Alvarez JI; Kébir H; Anandasabapathy N; Izquierdo G; Jung S; Obholzer N; Pochet N; Clish CB; Prinz M; Prat A; Antel J; Quintana FJ
    Nat Med; 2016 Jun; 22(6):586-97. PubMed ID: 27158906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability.
    Hindinger C; Bergmann CC; Hinton DR; Phares TW; Parra GI; Hussain S; Savarin C; Atkinson RD; Stohlman SA
    PLoS One; 2012; 7(7):e42088. PubMed ID: 22848713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
    Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
    J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.
    Ulivieri C; De Tommaso D; Finetti F; Ortensi B; Pelicci G; D'Elios MM; Ballerini C; Baldari CT
    Front Immunol; 2019; 10():1041. PubMed ID: 31134091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1.
    Smith BC; Tinkey RA; Brock OD; Mariam A; Habean ML; Dutta R; Williams JL
    J Neuroinflammation; 2023 Oct; 20(1):234. PubMed ID: 37828609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13.
    Mulas F; Wang X; Song S; Nishanth G; Yi W; Brunn A; Larsen PK; Isermann B; Kalinke U; Barragan A; Naumann M; Deckert M; Schlüter D
    Cell Mol Immunol; 2021 Jun; 18(6):1512-1527. PubMed ID: 32024978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
    Liu X; Zhou F; Yang Y; Wang W; Niu L; Zuo D; Li X; Hua H; Zhang B; Kou Y; Guo J; Kong F; Pan W; Gao D; Meves JM; Sun H; Xue M; Zhang Q; Wang Y; Tang R
    Glia; 2019 Jan; 67(1):101-112. PubMed ID: 30294880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis.
    Maier J; Kincaid C; Pagenstecher A; Campbell IL
    Am J Pathol; 2002 Jan; 160(1):271-88. PubMed ID: 11786421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis.
    Pagenstecher A; Lassmann S; Carson MJ; Kincaid CL; Stalder AK; Campbell IL
    J Immunol; 2000 May; 164(9):4481-92. PubMed ID: 10779748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; Ciric B; Touil T; Harle H; Grammatikopolou J; Das Sarma J; Gran B; Zhang GX; Rostami A
    J Immunol; 2007 Sep; 179(5):3268-75. PubMed ID: 17709543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis.
    Liu JQ; Carl JW; Joshi PS; RayChaudhury A; Pu XA; Shi FD; Bai XF
    J Immunol; 2007 May; 178(10):6227-35. PubMed ID: 17475850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.
    Lee J; Reinke EK; Zozulya AL; Sandor M; Fabry Z
    J Immunol; 2008 Nov; 181(9):6201-12. PubMed ID: 18941210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.